The Liver Core Center will provide technical and intellectual support and expertise for the liver-related research projects in the Schools of Medicine and Pharmacy of the University of California, San Francisco. It further will provide limited funds for pilot and feasibility studies. The Center will be based on the combined facilities and resources of the Schools of Medicine and Pharmacy, the Moffitt-University Hospital, the San Francisco Veterans Administration Hospital and the San Francisco General Hospital. The overall goals of the Center are to enhance the quality and productivity of individually funded research projects; to foster interdisciplinary communication and collaboration between investigators of different departments and schools; to stimulate new interdisciplinary research projects; to provide technical and procedural resources not available to individual research projects; to optimize the use of available technical and intellectual resources. The main emphasis of the Core Center will be on new and novel concepts and approaches to liver function and structure, both in the physiological state and in a variety of diseases, including drug-induced liver injury. The Core Center will be under the direction of a Program Director, two Deputy Directors, an Executive Committee and an Advisory Board, responsible to the Dean of the School of Medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK026743-07
Application #
3101983
Study Section
(SRC)
Project Start
1985-07-01
Project End
1990-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
von Morze, Cornelius (2018) Detecting liver injury non-invasively using hyperpolarized 13 C MRI. Liver Int 38:988-990
Huang, Annsa C; Mehta, Neil; Dodge, Jennifer L et al. (2018) Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout. Hepatology 68:449-461
Publicover, Jean; Gaggar, Anuj; Jespersen, Jillian M et al. (2018) An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Sci Transl Med 10:
Corbit, Kevin C; Camporez, João Paulo G; Edmunds, Lia R et al. (2018) Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling. Diabetes 67:208-221
Rubin, Jessica B; Hameed, Bilal; Gottfried, Michelle et al. (2018) Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol 16:936-946
Zhang, Shanshan; Wang, Jingxiao; Wang, Haichuan et al. (2018) Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. Am J Pathol 188:995-1006
Sarkar, Monika; Lai, Jennifer C; Sawinski, Deirdre et al. (2018) Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection. J Viral Hepat :
Xu, Zhong; Hu, Junjie; Cao, Hui et al. (2018) Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway. Exp Mol Med 50:e417
Chan, Rosa; Benet, Leslie Z (2018) Evaluation of the Relevance of DILI Predictive Hypotheses in Early Drug Development: Review of In Vitro Methodologies vs BDDCS Classification. Toxicol Res (Camb) 7:358-370
Sarkar, Monika; Baffy, Gyorgy (2018) Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality? Hepatology 67:7-9

Showing the most recent 10 out of 1119 publications